Literature DB >> 21834848

L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.

Andrzej Slominski1, Michal A Zmijewski, John Pawelek.   

Abstract

There is evidence that L-tyrosine and L-dihydroxyphenylalanine (L-DOPA), besides serving as substrates and intermediates of melanogenesis, are also bioregulatory agents acting not only as inducers and positive regulators of melanogenesis but also as regulators of other cellular functions. These can be mediated through action on specific receptors or through non-receptor-mediated mechanisms. The substrate induced (L-tyrosine and/or L-DOPA) melanogenic pathway would autoregulate itself as well as regulate the melanocyte functions through the activity of its structural or regulatory proteins and through intermediates of melanogenesis and melanin itself. Dissection of regulatory and autoregulatory elements of this process may elucidate how substrate-induced autoregulatory pathways have evolved from prokaryotic or simple eukaryotic organisms to complex systems in vertebrates. This could substantiate an older theory proposing that receptors for amino acid-derived hormones arose from the receptors for those amino acids, and that nuclear receptors evolved from primitive intracellular receptors binding nutritional factors or metabolic intermediates.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21834848      PMCID: PMC3242935          DOI: 10.1111/j.1755-148X.2011.00898.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  104 in total

1.  A possible role for melanin precursors in regulating both pigmentation and proliferation of melanocytes.

Authors:  J Pawelek; J Bolognia; J McLane; M Murray; M Osber; A Słominski
Journal:  Prog Clin Biol Res       Date:  1988

2.  L-tyrosine stimulates induction of tyrosinase activity by MSH and reduces cooperative interactions between MSH receptors in hamster melanoma cells.

Authors:  A Slominski; P Jastreboff; J Pawelek
Journal:  Biosci Rep       Date:  1989-10       Impact factor: 3.840

3.  Studies on factors influencing human plasma alpha-MSH.

Authors:  G Ghanem; J Verstegen; S De Rijcke; P Hanson; A Van Onderbergen; A Libert; V Del Marmol; R Arnould; A Vercammen-Grandjean; F Lejeune
Journal:  Anticancer Res       Date:  1989 Nov-Dec       Impact factor: 2.480

4.  Control of melanoblast differentiation in amphibia by alpha-melanocyte stimulating hormone, a serum melanization factor, and a melanization inhibiting factor.

Authors:  T Fukuzawa; J T Bagnara
Journal:  Pigment Cell Res       Date:  1989 May-Jun

5.  Are L-tyrosine and L-dopa hormone-like bioregulators?

Authors:  A Slominski; R Paus
Journal:  J Theor Biol       Date:  1990-03-08       Impact factor: 2.691

6.  A ventrally localized inhibitor of melanization in Xenopus laevis skin.

Authors:  T Fukuzawa; H Ide
Journal:  Dev Biol       Date:  1988-09       Impact factor: 3.582

7.  Phosphorylated mixed isomers of L-dopa increase melanin content in skins of Skh-2 pigmented hairless mice.

Authors:  P P Agin; R M Sayre; J M Pawelek
Journal:  Pigment Cell Res       Date:  1987

8.  L-tyrosine, L-dopa, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma cells.

Authors:  A Slominski; G Moellmann; E Kuklinska
Journal:  Pigment Cell Res       Date:  1989 Mar-Apr

9.  Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa.

Authors:  A Słominski; G Moellmann; E Kuklinska; A Bomirski; J Pawelek
Journal:  J Cell Sci       Date:  1988-03       Impact factor: 5.285

10.  MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.

Authors:  A Slominski; G Moellmann; E Kuklinska
Journal:  J Cell Sci       Date:  1989-04       Impact factor: 5.285

View more
  179 in total

1.  Melanoma resistance: a bright future for academicians and a challenge for patient advocates.

Authors:  Andrzej T Slominski; J Andrew Carlson
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

Review 2.  Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

Authors:  Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

Review 3.  Current position of TNF-α in melanomagenesis.

Authors:  Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip; Ioana Baldea
Journal:  Tumour Biol       Date:  2015-08-18

Review 4.  The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Wei Li; Ae-Kyung Yi; Arnold Postlethwaite; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-28       Impact factor: 4.292

5.  Kazinol U inhibits melanogenesis through the inhibition of tyrosinase-related proteins via AMP kinase activation.

Authors:  Jihyun Lim; Sorim Nam; Ji Hye Jeong; Min Jung Kim; Young Yang; Myeong-Sok Lee; Hee Gu Lee; Jae-Ha Ryu; Jong-Seok Lim
Journal:  Br J Pharmacol       Date:  2019-01-28       Impact factor: 8.739

Review 6.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

7.  Skin under the sun: when melanin pigment meets vitamin D.

Authors:  Andrzej Slominski; Arnold E Postlethwaite
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

8.  The role of melanin pigment in melanoma.

Authors:  Radomir M Slominski; Michal A Zmijewski; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2015-04       Impact factor: 3.960

9.  Targeting ALDH1A1 to treat pigmentary disorders.

Authors:  Konrad Kleszczynski; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2013-05       Impact factor: 3.960

10.  9-cis retinoic acid is the ALDH1A1 product that stimulates melanogenesis.

Authors:  Elyse K Paterson; Hsiang Ho; Rubina Kapadia; Anand K Ganesan
Journal:  Exp Dermatol       Date:  2013-03       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.